Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Celltrion Opens Up Canadian Market For Remsima SC
Launches Subcutaneous Version Of Biosimilar Infliximab Rival To Remicade
Jun 08 2021
•
By
David Wallace
Celltrion’s launch opens up the Canadian market for Remsima SC • Source: Alamy
More from Biosimilars
More from Products